<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Kowsar Medical Institute</publisher>
				<availability status="unknown"><p>Copyright Kowsar Medical Institute</p>
				</availability>
				<date type="published" when="2015-10-27">2015 October 27</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Samaneh</forename><surname>Khorrami</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Faculty of Medical Sciences</orgName>
								<orgName type="institution">Tarbiat Modares University</orgName>
								<address>
									<settlement>Tehran</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ahmad</forename><surname>Zavaran Hosseini</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seyed</forename><forename type="middle">Javad</forename><surname>Mowla</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Reza</forename><surname>Malekzadeh</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Digestive Oncology Research Center</orgName>
								<orgName type="institution" key="instit1">Digestive Diseases Research Institute</orgName>
								<orgName type="institution" key="instit2">Tehran University of Medical Sciences</orgName>
								<address>
									<settlement>Tehran</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Faculty of Medical Sciences</orgName>
								<orgName type="institution">Tarbiat Modares University</orgName>
								<address>
									<settlement>Tehran</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Iranian Journal of Cancer Prevention</title>
						<title level="j" type="abbrev">Iran J Cancer Preven</title>
						<idno type="ISSN">2008-2398</idno>
						<idno type="eISSN">2008-2401</idno>
						<imprint>
							<publisher>Kowsar Medical Institute</publisher>
							<biblScope unit="volume">8</biblScope>
							<biblScope unit="issue">5</biblScope>
							<date type="published" when="2015-10-27">2015 October 27</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.17795/ijcp-3446</idno>
					<idno type="PMID">26634106</idno>
					<idno type="PMCID">PMC4667234</idno>
					<ptr type="open-access" target="http://europepmc.org/articles/pmc4667234?pdf=render" />
					<note type="submission">Received 2015 July 6; Accepted 2015 October 1</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Colorectal Cancer</term>
					<term>Cancer Stem Cell</term>
					<term>HT-29</term>
					<term>ALDH</term>
					<term>Biomarker</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background: Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a functional stem cell biomarker to isolate CSCs in different cancers such as colorectal cancer. Objectives: The main aim of this research was to determine the utility of ALDH1 activity along with CD44 and EPCAM in identifying stem cell-like cells in human HT-29 colonic adenocarcinoma cell line. Materials and Methods: In this experimental study, colon CSCs biomarkers including CD44, EPCAM and ALDH1 in colonospheres and parent cells have analyzed by flow cytometry. The expression levels of stemness genes in spheroid and parental cells have investigated using SYBR Green real-time PCR. In addition, in vivo xenografts assay has performed to determine tumorigenic potential of tumor spheroid cells in nude mice. Results: According to results, over 92% of spheroids were CD44+/EpCAM+, while parent cells only have expressed 38% of CD44/EpCAM biomarkers (P &lt; 0.001). Controversially, ALDH activity was about 2-fold higher in the parent cells than spheroid cells (P &lt; 0.05). In comparison with the parental cells, expression levels of &apos;&apos;stemness&apos;&apos; genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P &lt; 0.05). Further, administration of 2500 spheroids could be sufficient to initiate tumor growth in nude mice, while 1x106 of parental cells has needed to form tumor. Conclusions: For the first time, we have shown that colonospheres with low ALDH1 activity has indicated increased tumorigenic potential and stemness properties. So, it hasn&apos;t seemed that ALDH1 could become a useful biomarker to identify CSCs population in HT-29 cell line.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Background</head><p>Increasing evidence has recently reported that malignancies have originated from a small population of cancer cells termed cancer stem cells (CSCs), indicating main properties including self-renewal and pluripotency. CSCs have widely known to responsible for initiating and sustaining tumor growth in all cancers including CRC <ref type="bibr" target="#b0">(1)</ref>. According to several studies, CRC tumorigenic cell population could mainly identified by the expression of specific cell surface biomarkers such as CD133 (Prominin-1) (2, 3), CD44 <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b4">5)</ref>, CD166 (ALCAM) (4, 6), CD24 <ref type="bibr" target="#b6">(7)</ref>, EpCAM (ESA) (4), CD29 <ref type="bibr" target="#b6">(7)</ref>, nuclear Î² catenin <ref type="bibr" target="#b6">(7)</ref>, Lgr5 (7), Oct-4, Sox-2, Nanog, Lin-28, Klf-4, C-myc <ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref><ref type="bibr" target="#b10">(10)</ref>.</p><p>It has shown that ALDH 1 induced proliferation and differentiation of stem cells through oxidizes of retinol to retinoic acid <ref type="bibr" target="#b11">(11)</ref>. High ALDH1 activity has used to define stem cell populations in large number of cancers including human multiple myeloma, acute myeloid leukemia <ref type="bibr" target="#b12">(12)</ref>, pancreatic cancer <ref type="bibr" target="#b13">(13)</ref> and breast cancer <ref type="bibr" target="#b14">(14)</ref>. Therefore, ALDH1 activity might be useful as a common biomarker for malignant stem cell populations <ref type="bibr" target="#b15">(15)</ref>.</p><p>More recently, it has reported that ALDH-1 as a useful biomarker for colon cancer stem cells <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b16">16)</ref>. Recent studies have shown that implantation of only 25 ALDH1+ colon cancer cells in NOD/SCID mice lead to tumor xenografts. Further isolation of colon cancer cells using a second marker (CD44 or CD133) has only modestly increased enrichment based on tumor-initiating ability <ref type="bibr" target="#b11">(11)</ref>. Therefore, ALDH1 has seemed to be a valuable biomarker for identifying and isolating human colonic SC during CRC development.</p><p>Based on existing evidence that cell lines have represented the tumors from which they have originally isolated <ref type="bibr" target="#b17">(17,</ref><ref type="bibr" target="#b18">18)</ref> and regarding the cumbersome accessibility to primary cancer cells isolated from patients, in this study we have selected a colon adenocarcinoma cell line, HT-29, as a model. To date, association of CSC markers such as CD44, EPCAM and CD24 have evaluated in HT-29 cell line however correlation between ALDH activity, as a novel biomarker in colon CSCs and tumorigenicity in this cell line have not investigated.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Objectives</head><p>In this study we have investigated stemness properties and colon CSCs markers in spheroid and parent cells of HT-29. Additionally in vivo xenografts assay has performed to evaluate tumorigenic potential of tumor spheroid cells.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Cell Line and Culture Conditions</head><p>In this experimental study, the human colonic adenocarcinoma cell line HT-29 (wild type, no: 300215) has purchased from Iranian Biological Resource Center (IBRC). Cells have cultured in Dulbecco's modified eagle medium: nutrient mixture F-12 (DMEM/F-12, 1:1, GIBCO, USA) supplemented with 10% fetal bovine serum (FBS, GIBCO, USA) and 1% penicillin/streptomycin (Invitrogen, USA) in a humidified incubator (Memert, Germany) at 37Â°C and 5% CO 2 . Cells have suspended using trypsinization (0.25% trypsin/EDTA (GIBCO, USA) for 3 -5 minutes)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Colonosphere Formation</head><p>For colonosphere formation, single-cell suspensions have cultured at a density of 15,000 to 20,000 cells/ mL in ultra-low attachment 6 well plates (Getbiofil, UK) in serum-free medium containing DMEM/F-12, supplemented with 20 ng/mL EGF (Sigma, USA) , 10 ng/mL FGF (Millipore, USA) and 1% B27 (50X, Invitrogen, USA) <ref type="bibr" target="#b19">(19)</ref>. To determine the differentiation potential of spheroid cells, tumor spheres have cultivated without EGF and FGF-2 in the presence of 10% serum.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Extreme Limiting Dilution Analysis</head><p>Extreme limiting dilution analysis (ELDA) has carried out to evaluate self-renewal capacity as previously explained by Hu and Smyth <ref type="bibr" target="#b20">(20)</ref>. Briefly, single cell suspension has obtained from parent and spheroid cells have plated at concentration of 1000, 100, 10 cells and 1 cell per well in 0.2 ml of CSC medium in 96-well ultra-low attachment (Getbiofil, UK) and cultured for 7 days in a humidified incubator at 37Â°C and 5% CO 2 . The number of wells containing of colonospheres has counted after 7 days. The frequency of sphere forming cells in a particular cell type has determined using ELDA web tool at http://bioinf.wehi.edu.au/software/elda.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">Evaluation of Surface Markers by Flow Cytometry</head><p>Single cell suspension from colonospheres and parent cells has stained according to standard protocol <ref type="bibr" target="#b19">(19)</ref>. Briefly, cells have detached by trypsin and re-suspended in PBS containing 1% BSA for 10 minutes on ice. Subsequently cells have washed and stained with anti-human/ mouse CD44-APC (eBioscience, USA) and anti-human EP-CAM-PE (Abcam, UK) for 20 minutes on ice. The cells have stained with rat IgG 2b isotype control APC (eBioscience, USA ) and mouse IgG 1 isotype control PE (Abcam, UK) have served as gating control. Flow-cytometry analysis was performed using FACS CantoII (BD, USA).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5.">Measurement of Aldehyde Dehydrogenase (ALDH) Activity</head><p>Identification of ALDH+ cells have performed using the ALDEFLUOR kit (StemCell Technologies, Canada). To perform the assay, an aliquot of the activated substrate has added to the colonospheres and parent cells suspended in ALDEFLUOR Assay Buffer. An aliquot of this cell mixture has immediately transferred to a tube containing DEAB for the control. These mixtures have incubated for 30 -60 minutes to allow conversion of the substrate to the fluorescent product. ALDH + cells have identified by comparing the fluorescence of test samples against background fluorescence from identical samples that have treated with the ALDH inhibitor diethylamino benzaldehyde (DEAB) by flow cytometry.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6.">Real-Time PCR</head><p>Total RNA has extracted from the parent and colonosphere-derived cells using high pure RNA isolation kit (Roche, USA) according to the manufacturer's instructions. cDNA has synthesized by Sensiscript Â® Reverse Transcription Kit (QIAGEN, USA) from total RNA and stored at -20Â°C until use. Quantitative reverse transcriptase PCR has performed to quantify the expression of stemness genes including c-myc, Klf-4, Nanog, Oct-4, Sox-2 using LightCycler FastStart Â® DNA Master PLUS SYBR GreenI (Roche, USA) according to the manufacturer's protocol on Roche light cycler version 3.5 (Roche, USA) . As an internal control for the normalization of these genes, Hypoxanthine-guanine phosphor ribosyl transferase (HGPRT) have used. PCR amplification has conducted with the following conditions: 1 cycle pre-incubation at 95Â°C for 10 minutes, followed by 40 cycles: denaturation for 10 seconds at 95Â°C, annealing for 10 seconds at 60Â°C or 61ÂºC, and extension for 10 seconds at 72Â°C. The primer sequences and specifications have summarized in <ref type="table">(Table  1</ref>). The relative amount of each mRNA has normalized to HGPRT. The fold-change from colonospheres relative to the control (parent) has calculated using 2-ÎÎCt method. Each sample has assayed in triplicate.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.7.">In Vivo Tumorigenicity</head><p>Tumorigenicity has determined by subcutaneous injection of single-cell suspensions from colonosphere and parent cells in 6 to 8 week-old female C57BL/6 nude mice. Before injection, cells have prepared at 1:1 ratio of PBS: collagen (sig-ma, USA) in a total volume of 100 ÂµL. 1 Ã10 3 , 2.5 Ã 10 3 and 5 Ã10 3 cells of colonospheres and 5 Ã10 5 and 1 Ã 10 6 of parent cells have injected in nude mice There were 3 mice in each group. Mice have purchased from animal laboratory of Imam Khomeini Hospital and maintained under standard conditions according to the guidelines of the animal care committee of cancer institute. Animal studies have approved by the animal ethics committee from Tarbiat Modares university. When tumor size has reached ~1 cm 3 , usually 7 -9 weeks after injection, mice have killed and tumors samples have obtained for pathology analysis and in vitro culture. Tumor volume has calculated by the following formula:</p><formula xml:id="formula_0">(1) (Short diameter) 2 Ã (long diameter) 2</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.8.">Statistical Analysis</head><p>Data have presented as means Â± standard error of the mean (SEM). Statistical analysis has performed using Graph-Pad Prism 3.0 (GraphPad Software Inc, USA). The unpaired t-test has used to analyze the median value of expression between the groups. Statistical significance has determined at P &lt; 0.05. All tests have performed in triplicate.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1.">Generation and Characterization of Colonospheres</head><p>In this study, we have found that human HT-29 colonic adenocarcinoma cells could form spheroid colonies in a serum-free medium containing. To investigate the capability of colon spheres differentiation, these cells have cultivated in 10% FBS medium rather than EGF and FGF-2. In present serum, spherical undifferentiated cells have attached to the plate, and differentiated into adherent cells with epithelial cell morphology <ref type="figure" target="#fig_1">(Figure 1)</ref>. In serum free condition, the expression levels of EpCAM and CD44 were significantly higher in spheroid than parent cells (P &lt; 0.001) ( <ref type="figure">Figure 2</ref>). The results have demonstrated that 92.3 Â± 3.6% of these tu-mor spheroid cells were CD44+/EpCAM+, while parent cells only have expressed 38.4 Â± 1.6% of CD44+/EpCAM+ markers. We have measured ALDH1 activity in colonospheres and parent cells-derived colonic HT-29 cell line. Interestingly, we have found that HT29 cells have exhibited substantially high levels of ALDH activity in the parent fractions in compared with the spheroid fractions. ALDH activity was 16.9 Â± 1.2 in spheroid cells in comparison with 34.6 Â± 2.3 in parental cells (P &lt; 0.05) <ref type="figure">(Figure 3)</ref>. We have evaluated the frequency of sphere-forming cells by doing an extreme limiting dilution analysis (ELDA) for spheroid and parent-derived HT-29 cells. The results have indicated that the frequency of spheroid formation in cell line -derived colonospheres were 6.4 fold higher than -derived the parent cells (P &lt; 0.005) ( <ref type="table" target="#tab_0">Table 2</ref>). The findings have suggested that colonospheres have formed by the colon cancer cell have enriched population of CSCs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2.">Stem-Like Features of Colonospheres In Vitro</head><p>To study the molecular features of colon CSCs, the expression of genes has involved in stem cell related pathways has investigated by real-time PCR in colonospere and parental cells, as shown in <ref type="figure" target="#fig_3">(Figure 4)</ref>.</p><p>In comparison with the parental cells, expression level of ''stemness'' genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P &lt; 0.05).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.">Colonospheres Can Generate Tumors Upon Xenotransplantation</head><p>To determine tumorigenicity in colonosphere and parental cells in vivo, nude mice have subcutaneously injected with either colonosphere or parent cells. The results have shown the ability of spheroid cells in tumor formation was significantly higher in comparison with parental cells ( <ref type="figure" target="#fig_4">Figure 5A</ref>). The data have shown that as few as 2500 spheroid cells were sufficient to induce tumor growth, whereas 1 Ã 10 6 of parental cells capable to form tumor <ref type="table" target="#tab_1">(Table 3)</ref>. Histological analyses have shown that tumors-induced of both xenografts have derived from spheroid and parental cells had the same character of original tumor ( <ref type="figure" target="#fig_4">Figure 5B</ref>).       </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Discussion</head><p>Previous studies have demonstrated that in addition to primary tumors, established cancer cell lines might be contained a subpopulation of cells possessing CSCs properties <ref type="bibr" target="#b21">(21,</ref><ref type="bibr" target="#b22">22)</ref>. In this research, we have identified and characterized CSCs in the colorectal cancer-derived cell line HT-29 through investigation of sphere formation and surface biomarkers. Studies have shown that under serum-free defined media, CSCs had ability to form floating spheroids <ref type="bibr" target="#b19">(19)</ref>. In consistent with previous observation, we have shown that in serum-free conditions HT-29 cell line could form spheroid colonies (colonospheres) and following exposure to 10% FBS differentiate into large and adherent cells , maintaining self-renewal capacity and differentiation potential.</p><p>Moreover, ELDA has resulted for survey functional CSCs in colonospheres has revealed that colonospheres has marked increasing frequency of cells with sphere-forming ability. Thus, it has suggested under extreme limited dilution and in serum-free conditions, spheroids could only formed from stem-like cells. Consequently, the formation of colonospheres with a very small number of HT-29 cell line has demonstrated enrichment CSCs in colono-spheres <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b20">20)</ref>.</p><p>Furthermore, we have shown that colonospheres have expressed the specifics markers including Sox2, Oct4, Nanog, C-myc and KLF4 which were important for stemness properties. In several studies have reported correlations between multi potent genes expression and stemness maintenance of human CSCs (8-10). Saigusa et al. has reported meaningful correlations among the expression level of OCT4, SOX2 and CD133 with distant recurrence, and poor prognosis of rectal cancer patients with preoperative chemo radiotherapy <ref type="bibr" target="#b8">(9)</ref>. Consistent with these results, Saiki et al. has also shown that lin-28 and SOX2 expression has highly associated with lymph node metastasis and Dukes stage <ref type="bibr" target="#b10">(10)</ref>.</p><p>Currently, several molecules have identified as markers for colon cancer stem cells such as CD133, CD44, CD166 and CD24 (2-6). Previous reports via flow cytometry analysis in tumor spheres and parent cells have shown associating between CD44 and EPCAM expression with colon CSCs. The results of present study has indicated significant expression of CD44 and EPCAM in colonospheres in comparison with parent cells so that colonospheres-de-rived cells were over 96% CD44+and EPCAM+. In line with these results, Kanwar et al. has shown that spheroid cells derived from HT-29 and HCT116 have higher expression of CD44 and EPCAM in comparison with parental cells <ref type="bibr" target="#b19">(19)</ref>. Thus these data strongly has indicated that colonospheres have generated under present conditions have mainly composed of CSCs.</p><p>More recently, ALDH1 has proposed as a promising new biomarker in normal and malignant human colonic SCs. Chu et al. has revealed that in vivo implantation of CD-44hi ALDH+ colon tumor cells were significantly more tumorigenic than matched CD44hi ALDH-cells. Therefore, as few as 100 CD44hi ALDH+ cells could lead to tumor formation <ref type="bibr" target="#b4">(5)</ref>. In addition, Huang et al. <ref type="bibr" target="#b16">(16)</ref> has shown that implantation of only 25 ALDH+ cancer cells have tumorigenicity in NOD/SCID mice. However, further isolation of cancer cells ALDH+ using CD44 or CD133 only modestly has resulted in tumor-initiating ability <ref type="bibr" target="#b11">(11)</ref>. Thus, we have suggested that ALDH1 activity could be a valuable biomarker for identifying CSC in colonosphere population. Controversy, our findings have revealed that colonospheres exhibit have decreased levels of ALDH1 activity in comparison with the corresponding parental cells. Nevertheless, low ALDH1 activity in colonospheres had no effect on their tumorigenic potential, so this population even has shown higher ability for initiating tumor, in comparison with parental cell with high ALDH1 activity in in vivo situation. Our results have shown that administration of 2500 colonospheres could be sufficient to initiate tumor growth in nude mice while 1 Ã 10 6 of parental cells has needed to form tumor. It would be important to point out that results of primary tumor could not generalized to colonic cell line like HT-29. The present data has indicated that there was no correlation between ALDH activity and the tumorigenic capacity, and it could not be as a universal biomarker for identifying CSCs.</p><p>Expression of ALDH1 could be different in population of tumor cell lines indicating CSCs properties. For instance, recently Yuval Shaked et al. has demonstrated that spheroid of U-87MG, MCF7, and PANC1cell lines rather than their types of parental have increased levels of ALDH1 activity. It has also shown that ALDH activity in A549 and HT-29 cells was substantially high levels in the parental in comparison with the spheroid. However, higher expression of p21 and p53 has found in spheroid of HT-29, showing more angiogenic effects and resistant to chemotherapy than parent cells <ref type="bibr" target="#b23">(23)</ref>. A similar result has also reported by Yu et al. who have shown that high level expression of ALDH or the present of CD44 in CSCs of prostate cancer cell lines could not be relevant with tumorigenicity capacity, so that ALDHlo CD44-cells and ALDHhiCD44+cells has exhibited the same proliferative, clonogenic and metastatic capacity, indicating their potential importance for further exploration <ref type="bibr" target="#b24">(24)</ref>.</p><p>Moreover, ALDH-melanoma cells could be equally resistant to treatment and tumorigenic with ALDH+ which indicates the functional ''marker'' ALDH has not played an exclusive role in tumor initiation and/or in low response to therapy <ref type="bibr" target="#b25">(25)</ref>.</p><p>For the first time, our current experimental data have shown that ALDH activity has not appeared to specifically identify CSCs in HT-29 cell line. It could suggested that isolation of CSC-derived HT-29 cell line base on CD44 and EPCAM markers might be useful for characterization and further investigation of this cell line.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Table 1 . 4 F</head><label>14</label><figDesc>The Primer Sequences and PCR Conditions : 5'-CCCAATTACCCATCCTTCC-3' 60ÂºC 303 bp R: 5'-GTGCCTGGTCAGTTCATC-3' HGPRT F: 5'-CCTGGCGTCGTGATTATGG-3' 60ÂºC 125 bp R: 5'-TCAGTCCTGTCCATAATTAGTCC-3'</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc>Generation Spheroid Cells From HT-29 Cell Line (A-D): Representative photographs have been showing colon cancer cells expanded in vitro as undifferentiated spheres in serum-free medium containing EGF and FGF-2. Pictures have shown a typical colon sphere observed by the inverted phase contrast microscope. (e): Microscopically analysis of colon cancer spheres have cultivated in differentiation conditions (growth factors removal and addition of 10% FBS) for 7 days (200 Ã).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .Figure 3 .</head><label>23</label><figDesc>Characterization of Colon CSCs in HT-29 Cell Line scattered plots of flow cytometry analyses have been showing CD44 and EPCAM positive cells in spheroid and parental cells. Iran J Cancer Prev. 2015;8Representative Flow Cytometry Plots for the Analysis of ALDH Enzymatic Activity in Spheroid and Parental Cells in the Presence of ALDH Substrate (BAAA) (Left and Middle Plots, Respectively) and in the Parental Cells in the Presence of ALDH Enzyme Inhibitor Diethylaminobenzaldehyde (DEAB) (Right Plot)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc>Stemness Genes Expression of Spheroid and Parental Cells Have Assessed by Real-Spheroid cells have shown higher expression of stemness genes, in comparison with parental cells (P &lt; 0.05). Results have presented as means Â± SEM. www.ijcancerprevention.com</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 .</head><label>5</label><figDesc>Tumorigenicity of Spheroid Cells In Vivo (A) The photograph of a representative mouse has taken at 7 weeks after cell transplantation (B) Haematoxylin-eosin analysis of mouse xenografts have generated by spheres expanded in culture (400 Ã). (C) Haematoxylin-eosin analysis of mouse xenografts have generated by parental cells expanded in culture (400 Ã)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 2 .Number of Cells/Well Number of Wells Plated Number of Wells Showing Colonospheres Colonospheres-Derived Cell Parent</head><label>2</label><figDesc>Extreme Limiting Dilution Analysis of Colonospheres Forming Frequency, by Parent and Colonospheres-Derived Cells of HT-29 a</figDesc><table><row><cell>1000</cell><cell>24</cell><cell>24</cell><cell>24</cell></row><row><cell>100</cell><cell>24</cell><cell>24</cell><cell>22</cell></row><row><cell>10</cell><cell>24</cell><cell>19</cell><cell>8</cell></row><row><cell>1</cell><cell>24</cell><cell>9</cell><cell>2</cell></row><row><cell>Sphere forming frequency (95% CI)</cell><cell></cell><cell>1.5 (1.3 -1.7)</cell><cell>1.32 (1.20 -1.51)</cell></row><row><cell>a P value &lt; 0.005.</cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 3 .</head><label>3</label><figDesc>Tumorigenicity of Colonospheres and Parental Cells From HT-29 Cell Lines in Nude Mice</figDesc><table><row><cell>Cell Type/Cell Number Injected</cell><cell>Tumor Incidence</cell><cell>Engraftment-Derived Spheres</cell></row><row><cell>Colonospheres</cell><cell></cell><cell></cell></row><row><cell>1 Ã 10 3</cell><cell>0/3</cell><cell>-</cell></row><row><cell>2.5 Ã 10 3</cell><cell>3/3</cell><cell>Yes</cell></row><row><cell>5 Ã 10 3</cell><cell>3/3</cell><cell>Yes</cell></row><row><cell>Parental cells</cell><cell></cell><cell></cell></row><row><cell>5 Ã 10 5</cell><cell>0/3</cell><cell>-</cell></row><row><cell>1 Ã 10 6</cell><cell>3/3</cell><cell>Yes</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Iran J Cancer Prev. 2015;8(5):e3446</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Iran J Cancer Prev. 2015;8(5):e3446 www.ijcancerprevention.com</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>We would like to express our gratitude to animal lab of Imam Khomeini hospital for providing nude mice. This study has financially supported by Tarbiat Modares university and digestive disease research institute of Tehran university, Tehran, Iran.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Footnotes</head><p>Authors' Contribution:All the authors have contributed to the design, and the interpretation and discussion of the results. All the authors have critically revised the manuscript.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest:</head><p>We had no conflicts of interest to declare.</p><p>Financial Disclosure:None declared.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Stem cells, cancer and cancer stem cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tannishtha</forename><surname>Reya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sean</forename><forename type="middle">J</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">F</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irving</forename><forename type="middle">L</forename><surname>Weissman</surname></persName>
		</author>
		<idno type="DOI">10.1038/35102167</idno>
		<idno type="PMID">11689955</idno>
		<ptr type="open-access" target="https://deepblue.lib.umich.edu/bitstream/2027.42/62862/1/414105a0.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">414</biblScope>
			<biblScope unit="issue">6859</biblScope>
			<biblScope unit="page" from="105" to="111" />
			<date type="published" when="2001-11" />
			<publisher>Springer Nature America, Inc</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 11689955</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Identification and expansion of human colon-cancer-initiating cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lucia</forename><surname>Ricci-Vitiani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dario</forename><forename type="middle">G</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emanuela</forename><surname>Pilozzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauro</forename><surname>Biffoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matilde</forename><surname>Todaro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cesare</forename><surname>Peschle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruggero</forename><surname>De Maria</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature05384</idno>
		<idno type="PMID">17122771</idno>
		<idno>doi: 10.1038/ nature05384</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">445</biblScope>
			<biblScope unit="issue">7123</biblScope>
			<biblScope unit="page" from="111" to="115" />
			<date type="published" when="2006-11-19" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 17122771</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">A human colon cancer cell capable of initiating tumour growth in immunodeficient mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catherine</forename><forename type="middle">A</forename><surname>Oâbrien</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aaron</forename><surname>Pollett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><surname>Gallinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">E</forename><surname>Dick</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature05372</idno>
		<idno type="PMID">17122772</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">445</biblScope>
			<biblScope unit="issue">7123</biblScope>
			<biblScope unit="page" from="106" to="110" />
			<date type="published" when="2006-11-19" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 17122772</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Phenotypic characterization of human colorectal cancer stem cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Dalerba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Dylla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I-K</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Hoey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Gurney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Simeone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A</forename><surname>Shelton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Parmiani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Castelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">F</forename><surname>Clarke</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0703478104</idno>
		<idno type="PMID">17548814</idno>
		<idno type="PMCID">PMC1891215</idno>
		<idno>doi: 10.1073/ pnas.0703478104</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/104/24/10158.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="10158" to="10163" />
			<date type="published" when="2007-06-04" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 17548814</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Characterization of a subpopulation of colon cancer cells with stem cell-like properties</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dana</forename><forename type="middle">J</forename><surname>Clanton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tracey</forename><forename type="middle">S</forename><surname>Snipas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Julia</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mai-Lan</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><surname>Hare</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">J</forename><surname>Peach</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.24061</idno>
		<idno type="PMID">19072981</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<title level="j" type="abbrev">Int. J. Cancer</title>
		<idno type="ISSN">0020-7136</idno>
		<idno type="ISSNe">1097-0215</idno>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1312" to="1321" />
			<date type="published" when="2009-03-15" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19072981</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Weichert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Knosel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bellach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Dietel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Kristiansen</surname></persName>
		</author>
		<idno type="DOI">10.1136/jcp.2004.016238</idno>
		<idno type="PMID">15509676</idno>
		<idno type="PMCID">PMC1770486</idno>
		<idno type="ark">ark:/67375/NVC-7CG26NQJ-W</idno>
		<idno type="istexId">6480C74F470F08947ABDB07D92AF8C88282D97B2</idno>
		<ptr type="open-access" target="https://jcp.bmj.com/content/57/11/1160.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Pathology</title>
		<title level="j" type="abbrev">Journal of Clinical Pathology</title>
		<idno type="ISSN">0021-9746</idno>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1160" to="1164" />
			<date type="published" when="2004-11-01" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 15509676</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Vermeulen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Todaro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>De Sousa Mello</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Sprick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kemper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Perez Alea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Richel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Stassi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Medema</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0805706105</idno>
		<idno type="PMID">18765800</idno>
		<idno type="PMCID">PMC2533206</idno>
		<ptr type="open-access" target="https://www.pnas.org/content/pnas/105/36/13427.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">36</biblScope>
			<biblScope unit="page" from="13427" to="13432" />
			<date type="published" when="2008-09-02" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 18765800</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dejuan</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yiwei</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhiwei</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fazlul</forename><surname>Sarkar</surname></persName>
		</author>
		<idno type="DOI">10.3390/cancers30100716</idno>
		<idno type="PMID">21643534</idno>
		<idno type="PMCID">PMC3106306</idno>
		<idno>doi: 10.3390/ cancers30100716</idno>
		<ptr type="open-access" target="http://www.mdpi.com/2072-6694/3/1/716/pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<title level="j" type="abbrev">Cancers</title>
		<idno type="ISSNe">2072-6694</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="716" to="729" />
			<date type="published" when="2011-02-21" />
			<publisher>MDPI AG</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 21643534</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susumu</forename><surname>Saigusa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Koji</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Toiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Yokoe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshinaga</forename><surname>Okugawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuhiro</forename><surname>Ioue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chikao</forename><surname>Miki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masato</forename><surname>Kusunoki</surname></persName>
		</author>
		<idno type="DOI">10.1245/s10434-009-0617-z</idno>
		<idno type="PMID">19657699</idno>
		<idno type="ark">ark:/67375/VQC-GJ4KBRC4-H</idno>
		<idno type="istexId">3791D0B57336C8BA250BB3BD70E7B34A8B08FD0B</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Surgical Oncology</title>
		<title level="j" type="abbrev">Ann Surg Oncol</title>
		<idno type="ISSN">1068-9265</idno>
		<idno type="ISSNe">1534-4681</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3488" to="3498" />
			<date type="published" when="2009-08-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
		<idno type="DOI">10.1245/s10434-009-0617-z.</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Surg Oncol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3488" to="98" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
	<note>PubMed: 19657699</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Comprehensive Analysis of the Clinical Significance of Inducing Pluripotent Stemness-Related Gene Expression in Colorectal Cancer Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasumitsu</forename><surname>Saiki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinya</forename><surname>Ishimaru</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Koshi</forename><surname>Mimori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasushi</forename><surname>Takatsuno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Makoto</forename><surname>Nagahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hideshi</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazutaka</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaki</forename><surname>Mori</surname></persName>
		</author>
		<idno type="DOI">10.1245/s10434-009-0567-5</idno>
		<idno type="PMID">19554373</idno>
		<idno type="ark">ark:/67375/VQC-CRBF3JG8-V</idno>
		<idno type="istexId">467299B24A2349630D767C5E13DC9DE4F6D37055</idno>
		<idno>doi: 10.1245/ s10434-009-0567-5</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Surgical Oncology</title>
		<title level="j" type="abbrev">Ann Surg Oncol</title>
		<idno type="ISSN">1068-9265</idno>
		<idno type="ISSNe">1534-4681</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2638" to="2644" />
			<date type="published" when="2009-06-25" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19554373</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Sven D</forename><surname>Mieog</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Esther</forename><forename type="middle">M</forename><surname>De Kruijf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Esther</forename><surname>Bastiaannet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">Jk</forename><surname>Kuppen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anita</forename><surname>Sajet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anton</forename><forename type="middle">Jm</forename><surname>De Craen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vincent</forename><forename type="middle">Thbm</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cornelis</forename><forename type="middle">Jh</forename><surname>Van De Velde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerrit-Jan</forename><surname>Liefers</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2407-12-42</idno>
		<idno type="PMID">22280212</idno>
		<idno type="PMCID">PMC3292491</idno>
		<ptr type="open-access" target="https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-12-42" />
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<title level="j" type="abbrev">BMC Cancer</title>
		<idno type="ISSNe">1471-2407</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">42</biblScope>
			<date type="published" when="2012-01-26" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 22280212</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christophe</forename><surname>Ginestier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min</forename><forename type="middle">Hee</forename><surname>Hur</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emmanuelle</forename><surname>Charafe-Jauffret</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Florence</forename><surname>Monville</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Julie</forename><surname>Dutcher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marty</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jocelyne</forename><surname>Jacquemier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrice</forename><surname>Viens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Celina</forename><forename type="middle">G</forename><surname>Kleer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suling</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><surname>Schott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Birnbaum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Max</forename><forename type="middle">S</forename><surname>Wicha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriela</forename><surname>Dontu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.stem.2007.08.014</idno>
		<idno type="PMID">18371393</idno>
		<idno type="PMCID">PMC2423808</idno>
		<idno>doi: 10.1016/j. stem.2007.08.014</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2423808?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<title level="j" type="abbrev">Cell Stem Cell</title>
		<idno type="ISSN">1934-5909</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="555" to="567" />
			<date type="published" when="2007-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 18371393</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Feldmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Dhara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Fendrich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Bedja</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Beaty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Mullendore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Karikari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Iacobuzio-Donahue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Jimeno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">L</forename><surname>Gabrielson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Matsui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Maitra</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-06-3281</idno>
		<idno type="PMID">17332349</idno>
		<idno type="PMCID">PMC3073370</idno>
		<ptr type="open-access" target="https://cancerres.aacrjournals.org/content/canres/67/5/2187.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2187" to="2196" />
			<date type="published" when="2007-03-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 17332349</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Moving Forward in Human Mammary Stem Cell Biology and Breast Cancer Prognostication Using ALDH1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Danuta</forename><surname>Balicki</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.stem.2007.10.015</idno>
		<idno type="PMID">18938743</idno>
		<ptr type="open-access" target="http://www.cell.com/article/S1934590907002329/pdf" />
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<title level="j" type="abbrev">Cell Stem Cell</title>
		<idno type="ISSN">1934-5909</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="485" to="487" />
			<date type="published" when="2007-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 18938743</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Aldehyde Dehydrogenase as a Marker for Stem Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jan</forename><forename type="middle">S</forename><surname>Moreb</surname></persName>
		</author>
		<idno type="DOI">10.2174/157488808786734006</idno>
		<idno type="PMID">19075754</idno>
	</analytic>
	<monogr>
		<title level="j">Current Stem Cell Research &amp; Therapy</title>
		<title level="j" type="abbrev">CSCR</title>
		<idno type="ISSN">1574-888X</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="237" to="246" />
			<date type="published" when="2008-12-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19075754</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Hynes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ginestier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Dontu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Appelman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Z</forename><surname>Fields</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Wicha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">M</forename><surname>Boman</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-08-4418</idno>
		<idno type="PMID">19336570</idno>
		<idno type="PMCID">PMC2789401</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/69/8/3382.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3382" to="3389" />
			<date type="published" when="2009-04-07" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19336570</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eleanor</forename><forename type="middle">J</forename><surname>Douglas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heike</forename><surname>Fiegler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><surname>Rowan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sarah</forename><surname>Halford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">C</forename><surname>Bicknell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><surname>Bodmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ian</forename><forename type="middle">P M</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nigel</forename><forename type="middle">P</forename><surname>Carter</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-04-0328</idno>
		<idno type="PMID">15256451</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/64/14/4817.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Res</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="4817" to="4825" />
			<date type="published" when="2004-07-15" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 15256451</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Cell culture of human colon adenomas and carcinomas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Willson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">N</forename><surname>Bittner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">D</forename><surname>Oberley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Meisner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Weese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2704" to="2717" />
			<date type="published" when="1987" />
		</imprint>
	</monogr>
	<note>PubMed: 3567899</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The Wnt/Î²-catenin pathway regulates growth and maintenance of colonospheres</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shailender</forename><forename type="middle">S</forename><surname>Kanwar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yingjie</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jyoti</forename><surname>Nautiyal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bhaumik</forename><forename type="middle">B</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adhip</forename><forename type="middle">Pn</forename><surname>Majumdar</surname></persName>
		</author>
		<idno type="DOI">10.1186/1476-4598-9-212</idno>
		<idno type="PMID">20691072</idno>
		<idno type="PMCID">PMC2924313</idno>
		<ptr type="open-access" target="https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/1476-4598-9-212" />
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer</title>
		<title level="j" type="abbrev">Molecular Cancer</title>
		<idno type="ISSN">1476-4598</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">212</biblScope>
			<date type="published" when="2010" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 20691072</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yifang</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gordon</forename><forename type="middle">K</forename><surname>Smyth</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jim.2009.06.008</idno>
		<idno type="PMID">19567251</idno>
		<idno>doi: 10.1016/j. jim.2009.06.008</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Immunological Methods</title>
		<title level="j" type="abbrev">Journal of Immunological Methods</title>
		<idno type="ISSN">0022-1759</idno>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="70" to="78" />
			<date type="published" when="2009-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19567251</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhi-Hua</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi-Fang</forename><surname>Ping</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shi-Cang</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liang</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao-Hong</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Hong</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">You-Hong</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiu-Wu</forename><surname>Bian</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2009.02.033</idno>
		<idno type="PMID">19324493</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Letters</title>
		<title level="j" type="abbrev">Cancer Letters</title>
		<idno type="ISSN">0304-3835</idno>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="92" to="99" />
			<date type="published" when="2009-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19324493</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The response of CD24(-/low)/ CD44+ breast cancer-initiating cells to radiation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">H</forename><surname>Mcbride</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Pajonk</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djj495</idno>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="1777" to="85" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
	<note>PubMed: 17179479</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Tumor-Initiating Cells of Various Tumor Types Exhibit Differential Angiogenic Properties and React Differently to Antiangiogenic Drugs</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liat</forename><surname>Benayoun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Svetlana</forename><surname>Gingis-Velitski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tali</forename><surname>Voloshin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ehud</forename><surname>Segal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rotem</forename><surname>Segev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michal</forename><surname>Munster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rotem</forename><surname>Bril</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronit</forename><surname>Satchi-Fainaro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefan</forename><forename type="middle">J</forename><surname>Scherer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuval</forename><surname>Shaked</surname></persName>
		</author>
		<idno type="DOI">10.1002/stem.1170</idno>
		<idno type="PMID">22782858</idno>
		<idno type="ark">ark:/67375/WNG-QHRHRBSR-G</idno>
		<idno type="istexId">36125B5F23CCB9333B27A2DEBEE91AFE122CDB4A</idno>
		<idno>doi: 10.1002/ stem.1170</idno>
	</analytic>
	<monogr>
		<title level="j">STEM CELLS</title>
		<title level="j" type="abbrev">STEM CELLS</title>
		<idno type="ISSN">1066-5099</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1831" to="1841" />
			<date type="published" when="2012-08-20" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 22782858</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Escara-Wilke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">In Vivo</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="69" to="76" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
	<note>PubMed: 21282737</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lina</forename><surname>Prasmickaite</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Birgit</forename><forename type="middle">Ã</forename><surname>EngesÃ¦ter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nirma</forename><surname>Skrbo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tina</forename><surname>Hellenes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexandr</forename><surname>Kristian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nina</forename><forename type="middle">K</forename><surname>Oliver</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhenhe</forename><surname>Suo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gunhild</forename><forename type="middle">M</forename><surname>MÃ¦landsmo</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0010731</idno>
		<idno type="PMID">20505780</idno>
		<idno type="PMCID">PMC2874003</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010731&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e10731</biblScope>
			<date type="published" when="2010-05-20" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 20505780</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
